Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

CHIEF SCIENTIFIC OFFICER

Chief Scientific Officer

Chief Medical Officer

Chief Financial Officer

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases in the United States. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovery, development, and commercializa...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-01-05	Premium	sold	Premium	Premium	Premium	CHIEF SCIENTIFIC OFFICER
2023-12-29	Premium	acquired	Premium	Premium	Premium	Chief Scientific Officer
2023-12-21	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-11-28	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-10-03	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-08-18	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-07-28	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-06-23	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-04-19	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-04-13	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-03-14	Premium	bought	Premium	Premium	Premium	-
2023-03-14	Premium	bought	Premium	Premium	Premium	-
2023-03-07	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-03-03	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-01-24	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-01-19	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-01-12	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2023-01-05	Premium	sold	Premium	Premium	Premium	Chief Scientific Officer
2022-12-29	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-11-28	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-11-02	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-10-13	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2022-10-03	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-09-01	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2022-08-30	Premium	sold	Premium	Premium	Premium	Chief Medical Officer

RAPT - RAPT Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for RAPT